S. Mouli , D. Rivera-Rodriguez , S. Ansari , M. Tate , R. Lukas , J. Weinstein , Y. Serulle , J. Boockvar , K. Narsinh , N. Butowski , M. Dreher , R. Stupp , R. Salem
{"title":"本年度摘要 FRONTIER 试验的初步结果:钇-90 TheraSphere治疗复发性胶质母细胞瘤的安全性和可行性","authors":"S. Mouli , D. Rivera-Rodriguez , S. Ansari , M. Tate , R. Lukas , J. Weinstein , Y. Serulle , J. Boockvar , K. Narsinh , N. Butowski , M. Dreher , R. Stupp , R. Salem","doi":"10.1016/j.jvir.2024.12.030","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"36 3","pages":"Page S3"},"PeriodicalIF":2.6000,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract No. 4 ▪ ABSTRACT OF THE YEAR Preliminary Results of the FRONTIER Trial: Safety and Feasibility of Yttrium-90 TheraSphere in Recurrent Glioblastoma\",\"authors\":\"S. Mouli , D. Rivera-Rodriguez , S. Ansari , M. Tate , R. Lukas , J. Weinstein , Y. Serulle , J. Boockvar , K. Narsinh , N. Butowski , M. Dreher , R. Stupp , R. Salem\",\"doi\":\"10.1016/j.jvir.2024.12.030\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":49962,\"journal\":{\"name\":\"Journal of Vascular and Interventional Radiology\",\"volume\":\"36 3\",\"pages\":\"Page S3\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2025-02-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Vascular and Interventional Radiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1051044324008194\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vascular and Interventional Radiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1051044324008194","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
Abstract No. 4 ▪ ABSTRACT OF THE YEAR Preliminary Results of the FRONTIER Trial: Safety and Feasibility of Yttrium-90 TheraSphere in Recurrent Glioblastoma
期刊介绍:
JVIR, published continuously since 1990, is an international, monthly peer-reviewed interventional radiology journal. As the official journal of the Society of Interventional Radiology, JVIR is the peer-reviewed journal of choice for interventional radiologists, radiologists, cardiologists, vascular surgeons, neurosurgeons, and other clinicians who seek current and reliable information on every aspect of vascular and interventional radiology. Each issue of JVIR covers critical and cutting-edge medical minimally invasive, clinical, basic research, radiological, pathological, and socioeconomic issues of importance to the field.